3086
D. Habibi et al. / Tetrahedron 69 (2013) 3082e3087
CHN: Anal. Calcd for C14H12N2O2: C, 69.99; H, 5.03; N, 11.66. Found:
C, 69.82; H, 4.84; N, 11.49.
812, 797, 748, 723, 666, 649, 632, 598, 553; 1H NMR (400 MHz,
DMSO-d6): dH 7.72 (d, J¼8.0 Hz, 2H), 7.67 (d, J¼8.4 Hz, 2H),
7.44e7.41 (dd, J¼2.4, 2.0 Hz, 1H), 7.37 (d, J¼8.0 Hz, 3H), 7.19 (d,
J¼8.8 Hz, 1H), 6.77e6.75 (d, J¼8.8 Hz, 1H), 6.61 (d, J¼2.4 Hz, 1H),
2.49 (s, 3H); 13C NMR (100 MHz, DMSO-d6): dC 156.4, 145.9, 145.8,
142.8,134.1,133.2,132.6,132.4,131.9,131.8,129.9,128.6,127.7,125.2,
117.0, 110.1, 104.0, 21.8; CHN: Anal. Calcd for C20H14Cl2N2O4S: C,
53.46; H, 3.14; N, 6.23. Found: C, 53.81; H, 3.21; N, 6.32.
4.3.8. 3-(2,6-Dimethylphenyl)-2-imino-2,3-dihydrobenzo[d]ox-azol-
5-ol (Table 2, entry 8). Yield 85%; mp 204e207 ꢀC; FT-IR (KBr,
cmꢁ1): 3347, 3315, 2954, 1862, 2688, 1679, 1616, 1475, 1379, 1296,
1178, 1101, 1003, 837, 798, 778, 728, 709, 634, 446; 1H NMR
(300 MHz, DMSO-d6): dH 9.30 (br s, 1H), 7.30e7.27 (m, 3H), 7.02 (d,
J¼8.2 Hz, 1H), 6.43 (br s, 1H), 6.36 (d, J¼7.6 Hz, 1H), 5.79 (d,
J¼2.3 Hz, 1H), 2.07 (s, 6H); 13C NMR (75 MHz, DMSO-d6): dC 154.7,
154.2, 137.7137.3, 133.9, 132.2, 129.5, 129.1, 109.5, 107.1, 95.6, 17.7;
CHN: Anal. Calcd for C15H14N2O2: C, 70.85; H, 5.55; N, 11.02. Found:
C, 70.34; H, 5.46; N, 10.87.
4.4.3. 3-(4-Iodophenyl)-2-imino-2,3-dihydrobenzo[d]oxazol-5-yl 4-
methylbenzenesulfonate (Table 3, entry 3). Yield 84%; mp
199e201 ꢀC; FT-IR (KBr, cmꢁ1): 3344, 3043, 1704, 1496, 1480, 1355,
1170, 1132, 1092, 893, 857, 819, 753, 592, 553; 1H NMR (400 MHz,
DMSO-d6): dH 7.89 (d, J¼8.4 Hz, 2H), 7.72 (d, J¼8.0 Hz, 2H), 7.36 (d,
J¼8.0 Hz, 3H), 7.24 (d, J¼8.4 Hz, 2H), 7.09 (d, J¼8.8 Hz, 1H), 6.66 (d,
J¼8.8 Hz, 1H), 6.58 (d, J¼2.4 Hz, 1H), 2.50 (s, 3H); 13C NMR
(100 MHz, DMSO-d6): dC 156.2, 145.7, 145.6, 142.9, 139.2, 133.7,
133.2, 131.9, 129.9, 128.7, 127.2, 116.0, 109.4, 103.6, 93.4, 21.8; CHN:
Anal. Calcd for C20H15IN2O4S: C, 47.44; H, 2.99; N, 5.53. Found: C,
47.52; H, 3.10; N, 5.64.
4.3.9. 3-(4-Methoxyphenyl)-2-imino-2,3-dihydrobenzo[d]oxaz-ol-5-
ol (Table 2, entry 9). Yield 84%; mp 177e180 ꢀC; FT-IR (KBr, cmꢁ1):
3336, 3089, 1673, 1617, 1579, 1499, 1479, 1414, 1294, 1196, 1161,
1090, 1011, 969, 833, 811, 744, 706, 625, 501; 1H NMR (300 MHz,
DMSO-d6): dH 9.30 (br s,1H), 7.45 (d, J¼8.1 Hz, 2H), 7.90 (d, J¼8.1 Hz,
2H), 6.98 (d, J¼8.3 Hz,1H), 6.55 (br s,1H), 6.34 (d, J¼8.3 Hz,1H), 6.18
(s, 1H), 3.80 (s, 3H); 13C NMR (75 MHz, DMSO-d6): dC 158.9, 155.5,
154.3, 137.2, 134.4, 127.9, 115.2, 109.3, 107.2, 96.1, 55.8; CHN: Anal.
Calcd for C14H12N2O3: C, 65.62; H, 4.72; N, 10.93. Found: C, 65.36; H,
4.61; N, 11.11.
4.4.4. 3-(2,6-Dimethylphenyl)-2-imino-2,3-dihydrobenzo[d]ox-azol-
5-yl 4-methylbenzenesulfonate (Table 3, entry 4). Yield 86%; mp
121e123 ꢀC; FT-IR (KBr, cmꢁ1): 3329, 3052, 1699, 1609, 1490, 1369,
1212, 1191, 1172, 1091, 988, 956, 864, 840, 822, 722, 745, 665, 652,
630, 599, 556, 525; 1H NMR (400 MHz, DMSO-d6): dH 7.68 (d,
J¼8.4 Hz, 2H), 7.36 (t, J¼7.6 Hz, 1H), 7.31 (d, J¼8.4 Hz, 2H), 7.25 (d,
J¼7.6 Hz, 2H), 7.16 (d, J¼8.8 Hz, 3H), 6.73 (d, J¼8.8 Hz, 1H), 6.17 (d,
J¼2.4 Hz, 1H), 2.46 (s, 3H), 2.09 (s, 6H); 13C NMR (100 MHz, DMSO-
d6): dC 156.8, 145.9, 145.6, 143.0, 137.2, 133.2, 131.8, 130.3, 129.8,
129.6, 129.4, 128.6, 115.9, 109.8, 103.2, 21.7, 17.7; CHN: Anal. Calcd
for C22H20N2O4S: C, 64.69; H, 4.94; N, 6.86. Found: C, 64.78; H, 4.86;
N, 6.94.
4.3.10. 3,30-(1,4-Phenylene)bis-(2-imino-2,3-dihydrobenzo[d]-ox-
azol-5-ol) (Table 2, entry 10). Yield 80%; mp 231e234 ꢀC; FT-IR (KBr,
cmꢁ1): 3329, 3069, 1674, 1618, 1521, 1480, 1396, 1292, 1190, 1161,
1110, 1007, 971, 810, 715, 640, 521; 1H NMR (300 MHz, DMSO-d6):
dH 9.35 (br s, 2H), 7.77 (s, 4H), 6.50e7.15 (m, 4H), 6.40 (d, J¼8.1 Hz,
4H); 13C NMR (75 MHz, DMSO-d6): dC 154.9, 154.4, 137.3, 134.0,
133.5, 127.1, 109.5, 107.7, 96.5; CHN: Anal. Calcd for C20H14N4O4: C,
64.17; H, 3.77; N, 14.97. Found: C, 63.94; H, 3.59; N, 14.78.
4.4. General experimental procedure for the synthesis of 2-
imino-3-aryl-2,3-dihydrobenzo[d]oxazol-5-yl 4-
methylbenzenesulfonate derivatives
4.4.5. 3,30-(1,4-Phenylene)bis(2-imino-2,3-dihydrobenzo[d]ox-azole-
5,3-diyl)bis(4-methylbenzenesulfonate) (Table 3, entry 5). Yield 85%;
mp 115 ꢀC dec; FT-IR (KBr, cmꢁ1): 3338, 3067, 1705,1617, 1598, 1519,
1485, 1454, 1381, 1292, 1257, 1219, 1193, 1180, 1132, 1091, 991, 956,
895, 862, 835, 814, 742, 664, 594, 552, 529; 1H NMR (400 MHz,
DMSO-d6): dH 7.76 (d, J¼8.4 Hz, 4H), 7.66 (s, 4H), 7.39 (d, J¼8.4 Hz,
6H), 7.04 (d, J¼8.8 Hz, 2H), 6.72 (s, 2H), 6.67 (d, J¼8.8 Hz, 2H), 2.50
(s, 6H); 13C NMR (100 MHz, DMSO-d6): dC 156.2, 145.7, 145.5, 142.9,
133.7, 133.2, 132.0, 129.9, 128.7, 126.7, 116.1, 109.4, 103.7, 21.8; CHN:
Anal. Calcd for C34H26N4O8S2: C, 59.81; H, 3.84; N, 8.21. Found: C,
59.90; H, 3.87; N, 8.27.
A mixture of 2-imino-3-aryl-2,3-dihydrobenzo[d]oxazol-5-ol
(1 mmol), p-toluenesulfonyl chloride (1 mmol) and K2CO3
(1 mmol) in EtOH (5 mL) was irradiated with ultrasound for the
appropriate time at room temperature. After completion (as mon-
itored by TLC), the solvent was concentrated and the solid residue
was washed with water to give the crude solid product. Then,
a crystallization step was performed using aqueous ethanol to af-
ford the pure product. The desired pure products were character-
ized by 1H NMR, 13C NMR, FT-IR, elemental analysis (CHN), and
melting points.
Acknowledgements
The authors are thankful to the Bu-Ali Sina University, Hamedan
Iran for the support of this work.
4.4.1. 3-(3-Bromophenyl)-2-imino-2,3-dihydrobenzo[d]oxazol-5-yl
4-methylbenzenesulfonate (Table 3, entry 1). Yield 87%; mp
189e190 ꢀC; FT-IR (KBr, cmꢁ1): 3334, 3086, 1702, 1590, 1495, 1478,
1430, 1388, 1363, 1221, 1192, 1171, 1135, 1092, 1071, 996, 888, 868,
850, 818, 784, 742, 722, 700, 684, 665, 653, 617, 594, 554, 520; 1H
NMR (400 MHz, DMSO-d6): dH 7.72 (d, J¼8.4 Hz, 2H), 7.64e7.61 (m,
2H), 7.45e7.44 (m, 2H), 7.37 (d, J¼8.4 Hz, 3H), 7.09 (d, J¼8.8 Hz, 1H),
6.69 (d, J¼8.8 Hz, 1H), 6.59 (d, J¼2.4 Hz, 1H), 2.49 (s, 3H); 13C NMR
(100 MHz, DMSO-d6): dC 156.2, 145.7, 145.6, 142.9, 135.3, 133.2,
131.9, 131.6, 131.3, 129.9, 128.7, 128.6, 124.2, 123.3, 116.1, 109.4, 103.5,
21.8; CHN: Anal. Calcd for C20H15BrN2O4S: C, 52.30; H, 3.29; N, 6.10.
Found: C, 52.42; H, 3.37; N, 6.21.
References and notes
1. (a) Majumdar, K. C.; Muhuri, S.; Islam, R. U.; Chattopadhyay, B. Heterocyclic
2009, 78, 1109; (b) Donald, C. R.; Richard, C. L. Tetrahedron Lett. 2009, 50, 4003;
(c) Lounasmaa, M.; Tolvanen, A. Nat. Prod. Rep. 2000, 17, 175; (d) Gribble, G. W. J.
Chem. Soc., Perkin Trans. 1 2000, 1045; (e) Lednicer, D.; Mitscher, L. A. Organic
Chemistry of Drug Synthesis; Wiley Interscienc: New York, 1997; Vol. 1; 226.
2. (a) Batenko, N. G.; Karlivans, G.; Valters, R. Chem. Het. Comp. 2005, 41, 691; (b)
Lenaz, G.; Genova, M. L. Encyclopedia Biol. Chem. 2004, 3, 621; (c) Aguilar-
Martinez, M.; Macias-Ruvalcaba, N. A.; Bautista-Martinez, J. A.; Gomez, M.;
Gonzalez, F. J.; Gonzalez, I. Curr. Org. Chem. 2004, 8, 1721; (d) Abraham, I.; Joshi,
R.; Pardasani, P.; Pardasani, R. T. J. Braz. Chem. Soc. 2011, 22, 385.
3. Vazquez, C.; Calabrese, J. C.; Dixon, D. A.; Miller, J. S. J. Org. Chem. 1993, 58, 65.
4. (a) Catalan, J.; Fabero, F.; Guijarro, M. S.; Claramunt, R. M.; Maria, M. D. S.;
Foces-Foces, M.; de la, C.; Cano, F. H.; Elguero, J.; Sastre, R. J. Am. Chem. Soc.
1990, 112, 747; (b) Ballesteros, P.; Claramunt, R. M.; Escolastico, C.; Maria, M. D.
S. J. Org. Chem. 1992, 57, 1873.
4.4.2. 3-(2,4-Dichlorophenyl)-2-imino-2,3-dihydrobenzo[d]ox-azol-
5-yl 4-methylbenzenesulfonate (Table 3, entry 2). Yield 85%; mp
164e166 ꢀC; FT-IR (KBr, cmꢁ1): 3339, 3038, 1711, 1693, 1597, 1491,
1476, 1369, 1221, 1194, 1171, 1130, 1093, 1078, 1163, 999, 900, 853,
5. Escolastico, C.; Maria, M. D. S.; Claramunt, R. M.; Jimeno, M. L.; Alkorta, I.;
Foces-Foces, C.; Cano, F. H.; Elguero, J. Tetrahedron 1994, 50, 12489.